Please provide your email address to receive an email when new articles are posted on . Imiquimod treatment for 16 weeks exhibited a 90% tumor clearance rate in persistent MMIS at margins of resection ...

A secondary analysis of the phase 3 KEYNOTE-716 trial finds that adjuvant Keytruda improves recurrence-free survival without increasing the risk of new primary melanoma and may reduce non-melanoma ...

Dear Doctors: My sister-in-law is 82 years old and was recently diagnosed with melanoma. She has an appointment for treatment in a couple of weeks. I thought this was a serious and deadly disease. Can ...

Impact of Environmental Tobacco Smoke on the Incidence of Mutations in Epidermal Growth Factor Receptor Gene in Never-Smoker Patients With Non–Small-Cell Lung Cancer We studied patients with a ...

Patients with small melanoma in situ (MIS) on low-risk body sites that was managed with 5-mm margins had a local recurrence rate of 0.9%, results from a retrospective case series from a single ...

Fecal microbiota profiles were observed to be significantly different among patients with melanoma and controls, as well as those with early-stage and late-stage melanoma. Fecal microbiota profiles ...

WASHINGTON, DC — A woman in her late 80s with mild dementia was recently referred to Vishal A. Patel, MD, director of cutaneous oncology at the George Washington (GW) Cancer Center, director of ...

Q: My sister-in-law is 82 years old and was recently diagnosed with melanoma. She has an appointment for treatment in a couple of weeks. I thought this was a serious and deadly disease. Can a patient ...

Dear Doctors: My sister-in-law is 82 years old and was recently diagnosed with melanoma. She has an appointment for treatment in a couple of weeks. I thought this was a serious and deadly disease. Can ...

Dear Doctors: My sister-in-law is 82 years old and was recently diagnosed with melanoma. She has an appointment for treatment in a couple of weeks. I thought this was a serious and deadly disease. Can ...